Triple NF-kB binding sites and LTR sequence similarities in HIV-1C isolates irrespective of helminth co-infection
© Mulu et al.; licensee BioMed Central Ltd. 2014
Received: 24 February 2014
Accepted: 25 April 2014
Published: 29 April 2014
Helminth infections as well as structural alternations in the long-terminal repeat (LTR) regions of HIV-1 are known to contribute to elevated HIV RNA level and enhance HIV-1 diseases progression. However, the impact of helminths infections on the occurrences of triple NF-κB and genetic variability in LTR region of HIV-1C isolates is not known. We aimed to examine the presence of genetic variability in the LTR region of HIV-1C isolates during chronic HIV-helminth co-infection.
HIV-1C infected Ethiopians with (n = 22) and without (n = 20) helminth infection were included. The LTR region of HIV was amplified and sequenced. Sequences were aligned with reference set from the Los Alamos HIV database. Phylogenetic analysis and frequency of polymorphic changes was performed by the neighbour-joining method using Geneious Basic software.
All LTR sequences from patients with or without of helminth co-infection clustered with HIV-1 subtype C with two distinct subclusters (C and C’). The enhancer element was found to have three copies of 10-base pair binding sites for NF-κBs which is an evidence for predominance of triple NF-κB sites (94%) in HIV-1C isolates irrespective of helminths co-infection and subclusters. Moreover, irrespective of helminth co-infection and C/C’ subclusters high sequences similarity in LTR was observed. There was no significant difference in plasma HIV RNA level between HIV-1 C and C’ subclusters.
Despite the small sample size, the predominance of triple NF-κB binding sites and high sequence similarities in LTR region irrespective of helminths infection suggest the natural occurrence of the three NF-κB binding sites in HIV-1C isolates without the influence of secondary infection. Thus, the higher HIV-1C viraemia in helminth co-infected individuals is more likely a result of immune activation rather than LTR sequence variation. Moreover, the lack of significant difference in plasma HIV RNA level between HIV-1 C and C’ subcluster may show the lack of functional differences among the two groups.
According to UNAIDS report, half of the people infected with HIV-1 in sub Saharan Africa are estimated to be co-infected with helminths  which may accelerate the course of HIV by augmenting viral replication [2, 3]. Immunologic evidence on the mechanisms by which chronic helminth infection may facilitate HIV-1 replication in co-infected individuals is well documented . It is suggested that HIV/helminths co-infected patients experience a shift from a Th1 to a predominantly Th2 response [4–6]. Consecutively, it has been speculated that chronic immune activation and the presence of a dominant Th2 cytokine environment may increase the risk of acquiring HIV infection [6, 7]. The chronic immune activation has been proposed as the main cause for elevated plasma HIV RNA level reported among sub Saharan Africa patients . The role of intestinal helminth co-infection and deworming on HIV viral load among acute sero-converters is controversial [9–12]. During chronic HIV-1 infection there is a sustained and dramatic immune activation characterized by elevated plasma levels of TNF-alpha, IL-1, and IL-6, which is directly correlated with plasma HIV RNA levels . We have recently observed higher HIV-1C viraemia in chronically helminthic co-infected patients, which was significantly reduced after 12 weeks of deworming .
Indeed, viral factors and their interaction with host factors also indicate the risk of HIV disease progression, elevated plasma HIV RNA level, and higher HIV transmission rate reported among sub Saharan African patients [13, 15]. For example, HIV-1 long-terminal repeat (LTR) is known to regulate viral gene expression by interacting with multiple viral and host factors. Reports on the contribution of structural alterations in the LTR region to disease progression and higher HIV transmission rate are controversial. Intracellular parasitic infection like Leishmania was found to be a potential activator for HIV replication and potent inducer of LTR transcription and viral replication in vitro. Moreover, the transcription factor NF-κB in the enhancer region of the LTR is activated through infection with viral and other pathogens independently . Activation of HIV-1 LTR transcription in host cells through complex biochemical pathways involving the participation of transcriptional factor NF-κB has been observed during leishmania parasite co-infection in vitro. The sequence of the enhancer element varies among HIV-1 subtypes . Triple NF-κB sequences have been described in most HIV-1C isolates [18–20] and believed to influence the viral fitness and higher replication and transmission. However, the relationship between the occurrences of triple NF-κB in most HIV-1C isolates and helminths co-infection is not known. During chronic HIV-1 infection with helminth co-infection, the ensuing immunological imbalance could conceivably lead to increased expression of co-receptor and transcriptional factors resulting in higher HIV RNA level and faster disease progression which may in turn result in active up-regulation of HIV LTR. Such functional shifts could be a result of structural alteration on the transcriptional factor NF-κB. We hypothesise that the higher HIV RNA level in helminths co-infected patients may also be associated with sequence alterations in LTR region . Thus, the aim of the current study was to examine the impact of helminths on genetic variability on LTR region of HIV-1 during chronic HIV-helminth co-infection.
This study was aimed to investigate the effect of helminths infection on the presence of alterations in regions and motifs of LTR during chronic HIV-helminths infection. The details of patient inclusion were described previously . Briefly, symptomatic HIV-infected persons above 18 years of age, seeking treatment and willing to participate were evaluated with a standardized form at enrolment. Patients were excluded for the following reasons or conditions: pregnancy, treatment with single dose nevirapine for prevention of mother-to-child transmission of HIV or any other antiretroviral therapy (ART), known diabetes, hypertension, epilepsy, liver, cardiac and renal diseases, genital ulcer or active tuberculosis at enrolment. T-cell count was made using flow cytometer (FACSCount, Becton Dickinson, San Jose, California, USA) following the manufacturer’s protocol. Plasma HIV-1 RNA level was determined by quantitative real time PCR (Abbott m2000rt instrument, Abbott Molecular, Des Plaines, IL, USA). The lower detection limit of the assay was 40 copies/ml (1.6 log10 RNA copies/ml).
The LTR region was amplified by nested PCR using a published protocol . Nucleic acid sequencing was performed using the inner primers and the ABI prism 310 Dye Terminator Cycle Sequencing Kit according to the manufacturing instruction (Applied Biosystems, Foster City, CA, USA). Sequences were aligned with reference set from the Los Alamos HIV database (http://www.hiv.lanl.gov). Phylogenetic analysis was performed by the neighbour-joining method with 1,000 bootstrap replicates under Kimura’s two-parameter correction using Geneious Basic software (http://www.geneious.com). The frequency of polymorphic changes (number of nucleotide changes found in each consensus sequence with respect to ETH2220 reference sequence divided by the total number of nucleotides sequenced) was calculated for enhancer, promoter regions and TRA elements of the LTR regions relevant for transcription.
Characteristics of the study participants at enrolment
With helminths (n = 87)
Without helminths (n = 133)
Age (Mean + SD)
31.4 ± 9a
33.7 ± 8
log10 HIV RNA (copies/ml)
4.83 ± 0.85
3.95 ± 0.96
CD4+ T cell/mm3
214 ± 142
212 ± 160
CD8+ T cell/mm3
970 ± 566
893 ± 427
LTR genetic variability on transcriptional and regulatory sites in HIV-1 subtype C chronically infected individuals with and without helminths coinfections
Mutation frequency (x10−2)a
With helminths infection
Without helminths infection
This is the first study, which examines the genetic variability of HIV-1C LTR region among chronically infected patients with and without helminths co-infection. The findings of LTR high genetic similarity in most of the regulatory sites irrespective of helminths co-infections may suggest the compensation of immunological imbalance [4, 13, 16, 18] which could be induced by both chronic HIV and helminths infections. Sequence inconsistency in the LTR binding sites (the promoter, enhancer, modulatory and TAR regions) have been observed in other subtypes. Nevertheless, it remains unclear for the majority of the clades that whether the observed sequence differences could influence the replicative capacity of the subtypes [16, 17]. The predominance of triple NF-κB sites in the current Ethiopian isolates is similar with previous studies from Africa and the rest of the world where subtype C is predominately circulating [17–20]. The occurrence of triple NF-κB sites with and without helminths infection shows the lack of association between helminths infection and presence of the third NF-κB sites; and is an additional evidence for the natural occurrence of triple NF-κB sites in HIV-1C isolates [17, 19], irrespective of co-infection. Thus, the biological influence of helminths could not directly determine genetic variability or similarity, suggesting that the observed high level of HIV-1C viraemia during chronic HIV-helminth co-infection [4, 6, 9–12, 14] is due to the immune activation [4, 8]. Although deletion of one or two NF-κB sites leads to substantially decreased replication levels , the subject 5627 (Figure 3) in the current study with deletion of the second NF-κB sites (11 nucleotides) had comparable HIV RNA level with the rest of the subject. Indeed, the function of this additional site may be altered during co-infection because of the immune dysregulation or activation.
Previous studies in Ethiopia showed the presence of two distinct subtypes C subclusters (C and C’) based on phylogenetic analysis of the env region [22–27] and the increasing of subcluster C’ overtime  although the epidemic of both strains began around the same time . The separate cluster of the LTR sequences from these chronically infected patients in the current study compared with Ethiopian reference isolates (ETH2220) strengthen previous studies that demonstrated that the Ethiopian subtype C had a genetic subcluster designated C’ in the LTR regions [22–27]. The genetic subclusters may indicate a different introduction of HIV in to Ethiopia  and diversity of the circulating HIV-1 C subtypes in the country. Although, the prevalence of C’ was increasing from 48% in 1988 to 70% in 1997 based on env gene [23, 26], indicating that C’ viruses may be spreading faster in Ethiopia, we found a higher C subcluster compared with C’ similar with previous report from central Ethiopia  indicating that when considering the LTR sequence the one from the C genotype may be advantageous in northwest Ethiopia. Unlike previous report , in the current study lack of significant difference in plasma HIV RNA level between HIV-1 C and C’ subcluster was observed and may show the lack of functional differences among the two groups. The 63.6% HIV-1 C subcluster in northwest Ethiopia is additional epidemiological evidence which demonstrates that subcluster C has deep rooted and is the predominant genotype currently circulating in northwest Ethiopia.
Despite the small sample size, the predominance of triple NF-κB sites and high sequence similarities in most LTR regions irrespective of helminths co-infection suggest the natural occurrence of additional NF-κB sites in HIV-1C isolates without the influence of helminths infection. Thus, the higher HIV-1C viraemia in helminth co-infected individuals is more likely a result of immune activation rather than LTR sequence variation. The lack of significant difference in plasma HIV RNA level between HIV-1 C and C’ subcluster may show the lack of functional differences among the two groups. However, it needs further studies to describe the role of HIV-1 C/C’ genetic variants in HIV-1 immunopathogenesis.
The authors would like to thank all study participants. Expert technical assistance by Sandra Bergs and Janka Rätzke is gratefully acknowledged.
This work was supported by German Academic Exchange Service (DAAD), Association of Sponsors and Friends of Leipzig University, and HIV/AIDS Prevention and Control Office of Amhara Regional State, Ethiopia.
- UNAIDS: Epidemic Update. 2010,http://www.unaids.org/globalreport/,Google Scholar
- Bentwich Z, Weisman Z, Grossman Z: Pathogenesis of AIDS in Africa-lessons from the Ethiopian immigrants in Israel. Immunologist. 1997, 5: 211-216.Google Scholar
- Lawn SD, Butera ST, Folks TM: Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infection. Clin Microbiol Rev. 2011, 14: 753-757.View ArticleGoogle Scholar
- Bentwich Z, Maartens G, Torten D, Bar-Yehuda , Kalikovich A: Concurrent infections and HIV pathogenesis. AIDS. 2071–2081, 12000: 4-Google Scholar
- Kassu A, Tsegaye A, Wolday D, Petros B, Aklilu M, Sanders EJ, Fontanet AL, Van Baarle D, Hamann D, De Wit TF: Role of incidental and/or cured intestinal parasitic infections on profile of CD4+ and CD8+ T cell subsets and activation status in HIV-1 infected and uninfected adult Ethiopians. Clin Exp Immunol. 2003, 132: 113-119. 10.1046/j.1365-2249.2003.02106.x.PubMed CentralView ArticlePubMedGoogle Scholar
- Borkow G, Bentwich Z: HIV and helminth co-infection: is deworming necessary?. Parasite Immunol. 2000, 28: 605-612.Google Scholar
- Morgan D, Whitworth J: The natural history of HIV-1 infection in Africa. Nat Med. 2001, 7: 143-145. 10.1038/84564.View ArticlePubMedGoogle Scholar
- Bentwich Z, Kalinkovich A, Weisman Z, Borkow G, Beyers N, Beyers A: Can eradication of helminthic infections change the face of AIDS and tuberculosis?. Immunol Today. 1999, 20: 485-487. 10.1016/S0167-5699(99)01499-1.View ArticlePubMedGoogle Scholar
- Wolday D, Mayaan S, Mariam ZG, Berhe N, Seboxa T, Britton S, Galai N, Landay A, Bentwich Z: Treatment of intestinal worms is associated with decreased HIV plasma viral load. J Acquir Immune Defic Syndr. 2002, 31: 56-62. 10.1097/00126334-200209010-00008.View ArticlePubMedGoogle Scholar
- Modjarrad K, Zulu I, Redden DT, Njobvu L, Lane HC, Bentwich Z, Vermund SH: Treatment of intestinal helminths does not reduce plasma concentrations of HIV-1 RNA in coinfected Zambian adults. J Infect Dis. 2005, 192: 1277-1283. 10.1086/444543.PubMed CentralView ArticlePubMedGoogle Scholar
- Hosseinipour MC, Napravnik S, Joaki G, Gama S, Mbeye N, Banda B, Martinson F, Hoffman I, Cohen MS: HIV and parasitic infection and the effect of treatment among adult outpatients in Malawi. J Infect Dis. 2007, 195: 1278-1282. 10.1086/513274.View ArticlePubMedGoogle Scholar
- Walson JL, Herrin BR, John-Stewart G: Deworming helminth co-infected individuals for delaying HIV disease progression. Cochrane Database Syst Rev. 2009, 3: CD006419-doi:10.1002/14651858.CD006419.pub3PubMedGoogle Scholar
- Graziosi C, Soudeyns H, Rizzardi PG: Immunopathogenesis of HIV infection. AIDS Res Hum Retroviruses. 1998, 14: S135-S142.PubMedGoogle Scholar
- Mulu A, Maier M, Liebert UG: Deworming of intestinal helminths reduces HIV-1 subtype C viremia in chronically co-infected individuals. Int J Infect Dis. 2013, 17: e897-e901. 10.1016/j.ijid.2013.03.022.View ArticlePubMedGoogle Scholar
- Alemu A, Shiferaw Y, Addis Z, Mathewos B, Birhan W: Effect of malaria on HIV/AIDS transmission and progression. Parasites & Vectors. 2013, 6: 18-10.1186/1756-3305-6-18. doi:10.1186/1756-3305-6-18View ArticleGoogle Scholar
- Olivier M, Badaró R, Medrano FJ, Moreno J: The pathogenesis of Leishmania/HIV co-infection: cellular and immunological mechanisms. Ann Trop Med Parasitol. 2000, 97: S79-S98.View ArticleGoogle Scholar
- Arellano Eva R, Soriano V, Alcami J, Holguin A: A new finding on the transcription regulation across different subtypes. AIDS Rev. 2006, 8: 9-16.Google Scholar
- De Baar MP, De Ronde A, Berkhout B, Cornelissen M, Van Der Horn KH, Van Der Schoot AM, De Wolf F, Lukashov VV, Goudsmit J: Subtype-Specific Sequence Variation of the HIV Type 1 Long Terminal Repeat and Primer-Binding Site. AIDS Res Hum Retroviruses. 2000, 16: 499-504. 10.1089/088922200309160.View ArticlePubMedGoogle Scholar
- Jeeninga RE, Hoogenkamp M, Armand-Ugon M, De Baar M, Verhoef K, Berkhout B: Functional Differences between the Long Terminal Repeat Transcriptional Promoters of Human Immunodeficiency Virus Type 1 Subtypes A through G. J Virol. 2000, 74: 3740-3751. 10.1128/JVI.74.8.3740-3751.2000.PubMed CentralView ArticlePubMedGoogle Scholar
- Bachu M, Yalla S, Asokan M, Verma A, Neogi U, Sharma S, Murali RV, Mukthey AB, Bhatt R, Chatterjee S, Rajan RE, Cheedarla N, Yadavalli VS, Mahadevan A, Shankar SK, Rajagopalan N, Shet A, Saravanan S, Balakrishnan P, Solomon S, Vajpayee M, Satish KS, Kundu TK, Jeang KT, Ranga U: Multiple NF-κB sites in HIV-1 subtype C LTR confer superior magnitude of transcription and thereby the enhanced viral predominance. J Biochem. 2012,http://www.jbc.org/cgi/doi/10.1074/jbc.M112.397158,Google Scholar
- Mulu A, Lange T, Liebert UG, Maier M: Clade homogeneity and Pol gene polymorphisms in chronically HIV-1 infected antiretroviral treatment naive patients after the roll out of ART in Ethiopia. BMC Infect Dis. 2014, 14: 158-10.1186/1471-2334-14-158. Doi: 10.1186/1471-2334-14-158PubMed CentralView ArticlePubMedGoogle Scholar
- Kassu A, Fujino M, Matsuda M, Nishizawa M, Ota F, Sugiura W: Molecular epidemiology of HIV-1 in treatment naive patients in North Ethiopia. AIDS Res Hum Retroviruses. 2007, 23: 564-568. 10.1089/aid.2006.0270.View ArticlePubMedGoogle Scholar
- Pollakis G, Abebe A, Kliphuis A, De Wit TF, Fisseha B, Tegbaru B, Tesfaye G, Negassa H, Mengistu Y, Fontanet AL, Cornelissen M, Goudsmit J: Recombination of HIV type 1C (C’/C") in Ethiopia: Possible link of EthHIV-1C’ to subtype C sequences from the high-prevalence epidemics in India and Southern Africa. AIDS Res Hum Retroviruses. 2003, 19: 999-1008. 10.1089/088922203322588350.View ArticlePubMedGoogle Scholar
- Abebe A, Pollakis G, Fontanet AL, Fisseha B, Tegbaru B, Kliphuis A, Tesfaye G, Negassa H, Cornelissen M, Goudsmit J, Rinke De Wit TF: Identification of a genetic subcluster of HIV type 1 subtype C (C’) widespread in Ethiopia. AIDS Res Hum Retroviruses. 2000, 16: 1909-1914. 10.1089/08892220050195865.View ArticlePubMedGoogle Scholar
- Abebe A, Lukashov VV, Rinke De Wit TF, Fisseha B, Tegbaru B, Kliphuis A, Tesfaye G, Negassa H, Fontanet AL, Goudsmit J, Pollakis G: Timing of the introduction into Ethiopia of subcluster C’ of HIV type 1 subtype C. AIDS Res Hum Retroviruses. 2001, 17: 657-661. 10.1089/088922201300119770.View ArticlePubMedGoogle Scholar
- Ayele W, Mekonnen Y, Messele T, Mengistu Y, Tsegaye A, Bakker M, Berkhout B, Dorigo-Zetsma W, Wolday D, Goudsmit J, Coutinho R, De Baar M, Paxton W, Pollakis G: Differences in HIV Type 1 RNA plasma load profile of closely related cocirculating Ethiopian subtype C strains: C and C’. AIDS Res Hum Retroviruses. 2010, 26: 805-813. 10.1089/aid.2009.0152.View ArticlePubMedGoogle Scholar
- De Baar M, Abebe A, Kliphuis A, Tesfaye G, Goudsmit J, Pollakis G: HIV Type 1 C and C’ subclusters based on long terminal repeat sequences in the Ethiopian HIV type 1 subtype C epidemic. AIDS Res Hum Retroviruses. 2002, 19: 917-922.View ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.